Industries > Pharma > Global Live Vaccines Market Forecast 2020-2030
Global Live Vaccines Market Forecast 2020-2030
Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others PLUS analysis on leading companies in the Live Vaccines Market
The global live vaccines market was valued at $10,423.4 mn in 2019 and is anticipated to surpass $ 20,020 mn by 2030. In 2019, the North American segment held 39% of the global live vaccines market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 213-page report you will receive 138 tables and 65 figures– all unavailable elsewhere.
The 213-page report provides clear detailed insight into the live vaccines market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Live Vaccines Market from 2020-2030
• Forecast of the Global Live Vaccines Market by Type of Product:
• Bacterial
• Viral
• Forecast of the Global Live Vaccines Market by Indication:
• Oral Polio Vaccine (OPV)
• Measles
• Rotavirus
• Tuberculosis
• Yellow Fever
• Others
• This report provides individual revenue forecasts to 2030 for these national markets:
• The US
• Canada
• Germany
• France
• UK
• Italy
• Spain
• Japan
• China
• India
• Brazil
• Mexico
• Our study discusses the selected leading companies that are the major players in the live vaccines market:
• AstraZeneca
• Bavarian Nordic A/S
• DAIICHI SANKYO COMPANY, LIMITED
• Emergent BioSolutions Inc.
• GlaxoSmithKline plc
• Inovio Pharmaceuticals, Inc.
• & Other Companies
• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.
• This report discusses the SWOT & PEST Analyses of the live vaccines market.
Visiongain’s study is intended for anyone requiring commercial analyses for the live vaccines market. You find data, trends and predictions.
Buy our report today Global Live Vaccines Market Forecast 2020-2030: Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Why You Should Read This Report
1.2 How This Report Delivers
1.3 Key Questions Answered by This Analytical Report:
1.4 Who is This Report for?
1.5 Methodology
1.5.1 Primary Research
1.5.2 Secondary Research
1.5.3 Market Evaluation & Forecasting Methodology
1.6 Frequently Asked Questions
1.7 Associated Reports
1.8 About Visiongain
2. Introduction to Live Vaccines
2.1 What are Live Vaccines?
2.2 Pros and Cons of Live, Attenuated Vaccines
2.3 WHO recommended vaccines using LAV Technology
2.4 Current Status of Vaccine Development
2.5 Role of Federal Agencies
2.6 Drug Development and Approval Process
2.7 Social and Economic Burden
3. Market Overview
3.1 Market Structure
3.2 Classification by Type
3.2.1 Bacterial
3.2.2 Viral
3.3 Classification by Indication
3.3.1 Oral Polio Vaccine (OPV)
3.3.2 Measles
3.3.3 Rotavirus
3.3.4 Tuberculosis
3.3.5 Yellow Fever
3.3.6 Others
3.4 Classification by Route of Administration
3.4.1 Oral
3.4.2 Injectable
3.5 Classification by End Users
4. Global Live Vaccines Market, 2020-2030
4.1 Global Live Vaccines Market, 2019
4.2 Global Live Vaccines Market Forecast, 2020-2030
4.3 Global Live Vaccines by Type
4.3.1 Global Live Vaccines by Type: Market Forecasts 2020-2030
4.4 Global Live Vaccines by Indication
4.4.1 Global Live Vaccines by Indication: Market Forecasts 2020-2030
4.5 Global Live Vaccines by Route of Administration
4.5.1 Global Live Vaccines by Route of Administration: Market Forecasts 2020-2030
4.6 Global Live Vaccines by End User
4.6.1 Global Live Vaccines by End User: Market Forecasts 2020-2030
5. Leading National Markets Forecast 2020-2030
5.1 Geographical Breakdown of Global Live Vaccines Market, 2019
5.1.1 Regional Breakdown of Global Live Vaccines Market, 2019
5.1.2 Country Breakdown of Global Live Vaccines Market, 2020
5.2 Regional Forecast of Global Live Vaccines Market, 2019-2030
5.3 North America Live Vaccines Market, 2020-2030
5.3.1 U.S. Live Vaccines Market Forecast, 2020-2030
5.3.2 Canada Live Vaccines Market Forecast, 2020-2030
5.4 Europe Live Vaccines Market, 2020-2030
5.4.1 Germany Live Vaccines Market Forecast, 2020-2030
5.4.2 France Live Vaccines Market Forecast, 2020-2030
5.4.3 UK Live Vaccines Market Forecast, 2020-2030
5.4.4 Italy Live Vaccines Market Forecast, 2020-2030
5.4.5 Spain Live Vaccines Market Forecast, 2020-2030
5.5.6 Rest of Europe Live Vaccines Market Forecast, 2020-2030
5.5 Asia Pacific Live Vaccines Market, 2020-2030
5.5.1 Japan Live Vaccines Market Forecast, 2020-2030
5.5.2 China Live Vaccines Market Forecast, 2020-2030
5.5.3 India Live Vaccines Market Forecast, 2020-2030
5.5.4 Rest of APAC Live Vaccines Market Forecast, 2020-2030
5.6 Latin America Live Vaccines Market, 2020-2030
5.6.1 Brazil Live Vaccines Market Forecast, 2020-2030
5.6.2 Mexico Live Vaccines Market Forecast, 2020-2030
5.6.3 Rest of Latin America Live Vaccines Market Forecast, 2020-2030
5.7 MEA Live Vaccines Market, 2020-2030
5.7.1 GCC Countries Live Vaccines Market Forecast, 2020-2030
5.7.2 South Africa Live Vaccines Market Forecast, 2020-2030
5.7.3 Rest of MEA Live Vaccines Market Forecast, 2020-2030
6. Qualitative Analysis of the Global Live Vaccines Market
6.1 SWOT Analysis of Global Live Vaccines Market
6.1.1 Strengths
6.1.2 Weakness
6.1.3 Opportunities
6.1.4 Threats
6.2 PEST Analysis
6.3 Market Trends
6.4 Market Drivers
6.4.1 Growing investment in vaccine development
6.4.2 High prevalence of infectious diseases
6.4.3 Rising Research and Development Activities
6.4.4 Increase in Government Focus on Immunization Programs
6.5 Market Restraints
6.5.1 Inadequate Reimbursement Coverage
6.5.2 Longer timelines required for Vaccine Production
6.5.3 Stringent Government Regulations for the Approval of Products
6.6 Market Challenges
6.6.1 Inadequate Access to Vaccines
6.6.2 Product Recalls
6.7 Market Opportunities
6.7.1 Growing demand from emerging economies
7. Leading Companies in Global Live Vaccines Market, 2020
7.1 Sanofi
7.2 Emergent BioSolutions Inc.
7.3 GlaxoSmithKline plc
7.4 Pfizer Inc.
7.5 Merck & Co., Inc.
7.6 DAIICHI SANKYO COMPANY, LIMITED
7.7 Inovio Pharmaceuticals, Inc.
7.8 Serum Institute of India
7.9 Bavarian Nordic
7.10 Mitsubishi Tanabe Pharma Corporation
7.11 AstraZeneca
7.12 Vivaldi Biosciences Inc.
8. Conclusions
9. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Tables
Table 4.1 Global Live Vaccines Market by Sub-Markets: Revenue ($m), and Market Share (%), 2019
Table 4.2 Global Live Vaccines Market Forecast 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 4.3 Global Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 4.4 Global Live Vaccines Market by Type 2020-2030: AGR (%)
Table 4.5 Global Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 4.6 Global Live Vaccines Market by Indication 2020-2030: AGR (%)
Table 4.7 Global Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 4.8 Global Live Vaccines Market by Type 2020-2030: AGR (%)
Table 4.9 Global Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 4.10 Global Live Vaccines Market by End User 2020-2030: AGR (%)
Table 5.1 Global Live Vaccines Market by Region: Revenue ($m), and Market Share (%), 2019
Table 5.2 Global Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019
Table 5.3 Global Live Vaccines Market Forecast by Region, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.4 North America Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019
Table 5.5 North America Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.6 North America Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.7 North America Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.8 North America Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.9 U.S. Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.10 U.S. Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.11 U.S. Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.12 U.S. Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.13 Canada Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.14 Canada Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.15 Canada Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.16 Canada Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.17 Europe Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019
Table 5.18 Europe Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.19 Europe Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.20 Europe Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.21 Europe Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.22 Germany Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.23 Germany Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.24 Germany Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.25 Germany Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.26 France Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.27 France Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.28 France Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.29 France Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.30 UK Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.31 UK Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.32 UK Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.33 UK Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.34 Italy Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.35 Italy Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.36 Italy Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.37 Italy Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.38 Spain Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.39 Spain Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.40 Spain Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.41 Spain Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.42 Rest of Europe Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.43 Rest of Europe Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.44 Rest of Europe Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.45 Rest of Europe Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.46 Asia Pacific Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019
Table 5.47 Asia Pacific Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.48 Asia Pacific Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.49 Asia Pacific Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.50 Asia Pacific Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.51 Japan Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.52 Japan Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.53 Japan Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.54 Japan Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.55 China Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.56 China Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.57 China Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.58 China Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.59 India Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.60 India Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.61 India Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.62 India Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.63 Rest of APAC Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.64 Rest of APAC Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.65 Rest of APAC Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), CAGR (%)
Table 5.66 Rest of APAC Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), CAGR (%)
Table 5.67 Latin America Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019
Table 5.68 Latin America Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.69 Latin America Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.70 Latin America Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.71 Latin America Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.72 Brazil Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.73 Brazil Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.74 Brazil Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.75 Brazil Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.76 Mexico Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.77 Mexico Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.78 Mexico Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.79 Mexico Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.80 Rest of Latin America Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.81 Rest of Latin America Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.82 Rest of Latin America Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR(%), CAGR (%)
Table 5.83 Rest of Latin America Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.84 MEA Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019
Table 5.85 MEA Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.86 MEA Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.87 MEA Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.88 MEA Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.89 GCC Countries Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.90 GCC Countries Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.91 GCC Countries Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.92 GCC Countries Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.93 South Africa Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.94 South Africa Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.95 South Africa Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.96 South Africa Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.97 Rest of MEA Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.98 Rest of MEA Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.99 Rest of MEA Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 5.100 Rest of MEA Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)
Table 7.1 Company: Snapshot
Table 7.2: Product/Pipeline
Table 7.3: Product/Pipeline
Table 7.4 Company: Snapshot
Table 7.5: Product/Pipeline
Table 7.6: Recent Developments
Table 7.7 Company: Snapshot
Table 7.8: Product/Pipeline
Table 7.9 Company: Snapshot
Table 7.10: Product/Pipeline
Table 7.11 Company: Snapshot
Table 7.12: Product/Pipeline
Table 7.13 Company: Snapshot
Table 7.14: Product/Pipeline
Table 7.15 Company: Snapshot
Table 7.16: Product/Pipeline
Table 7.17: Recent Developments
Table 7.18 Company: Snapshot
Table 7.19: Product/Pipeline
Table 7.20 Company: Snapshot
Table 7.21: Product/Pipeline
Table 7.22: Recent Developments
Table 7.23 Company: Snapshot
Table 7.24: Product/Pipeline
Table 7.25 Company: Snapshot
Table 7.26 Company: Product/Pipeline
Table 7.27 Company: Snapshot
Table 7.28: Product/Pipeline
List of Figures
Figure 2.1 Vaccine Types, WHO
Figure 3.1 Global Live Vaccines Market Segmentation Overview
Figure 3.2 Live Vaccines Classification by Type, 2020
Figure 3.3 Bacterial Market, 2019-2030 (Revenue: $mn)
Figure 3.4 Medical conditions associated with viral vaccines
Figure 3.5 Viral Market, 2019-2030 (Revenue: $mn)
Figure 3.6 Live Vaccines Classification by Indication, 2020
Figure 3.7 Global Vaccination Coverage, 1980-2018
Figure 3.8 Global Vaccination Coverage, 2010-2018
Figure 3.9 Global Vaccination Coverage, 2018
Figure 3.10 Deaths Caused by Vaccine-Preventable Diseases Globally, 2017
Figure 3.11 Supply History and Breakdown of OPV Vaccines and WAP Trend
Figure 3.12 OPV Market, 2019-2030 (Revenue: $mn)
Figure 3.13 Measles Market, 2019-2030 (Revenue: $mn)
Figure 3.14 Rotavirus Market, 2019-2030 (Revenue: $mn)
Figure 3.15 Share of One-Year-Olds Vaccinated Against Rotavirus
Figure 3.16 Tuberculosis Market, 2019-2030 (Revenue: $mn)
Figure 3.17 Yellow Fever Market, 2019-2030 (Revenue: $mn)
Figure 3.18 Others Market, 2019-2030 (Revenue: $mn)
Figure 3.19 Live Vaccines Classification by Route of Administration, 2020
Figure 3.20 Global Live Vaccines Market by Route of Administration, 2019-2030 (Revenue: $mn)
Figure 3.21 Oral Market, 2019-2030 (Revenue: $mn)
Figure 3.22 Injectable Market, 2019-2030 (Revenue: $mn)
Figure 3.23 Live Vaccines Classification by End Users, 2020
Figure 3.24 Global Live Vaccines Market by End Users, 2019-2030 (Revenue: $mn)
Figure 4.1 Global Live Vaccines Market by Type: Market Share (%), 2019
Figure 4.2 Global Live Vaccines Market by Indication: Market Share (%), 2019
Figure 4.3 Global Live Vaccines Market by Route of Administration: Market Share (%), 2019
Figure 4.4 Global Live Vaccines Market by End User: Market Share (%), 2019
Figure 4.5 Global Live Vaccines Market by Region: Market Share (%), 2019
Figure 4.6 Global Live Vaccines Market Forecast 2019-2030: Revenue ($m), AGR (%)
Figure 4.7 Global Live Vaccines Market by Type: Market Share (%), 2020
Figure 4.8 Global Live Vaccines Market by Type: Market Share (%), 2025
Figure 4.9 Global Live Vaccines Market by Type: Market Share (%), 2030
Figure 4.10 Global Live Vaccines Market by Indication: Market Share (%), 2020
Figure 4.11 Global Live Vaccines Market by Indication: Market Share (%), 2025
Figure 4.12 Global Live Vaccines Market by Indication: Market Share (%), 2030
Figure 4.13 Global Live Vaccines Market by Route of Administration: Market Share (%), 2020
Figure 4.14 Global Live Vaccines Market by Route of Administration: Market Share (%), 2025
Figure 4.15 Global Live Vaccines Market by Route of Administration: Market Share (%), 2030
Figure 4.16 Global Live Vaccines Market by End User: Market Share (%), 2020
Figure 4.17 Global Live Vaccines Market by End User: Market Share (%), 2025
Figure 4.18 Global Live Vaccines Market by End User: Market Share (%), 2030
Figure 5.1 Global Live Vaccines Market Segmentation by Region/Country
Figure 5.2 Global Live Vaccines Market by Country: Market Share (%), 2020
Figure 5.3 Global Live Vaccines Market by Country: Market Share (%), 2025
Figure 5.4 Global Live Vaccines Market by Country: Market Share (%), 2030
Figure 5.5 North America Live Vaccines Market by Country: Market Share (%), 2020
Figure 5.6 North America Live Vaccines Market by Country: Market Share (%), 2025
Figure 5.7 North America Live Vaccines Market by Country: Market Share (%), 2030
Figure 5.8 Europe Live Vaccines Market by Country: Market Share (%), 2020
Figure 5.9 Europe Live Vaccines Market by Country: Market Share (%), 2025
Figure 5.10 Europe Live Vaccines Market by Country: Market Share (%), 2030
Figure 5.11 Asia Pacific Live Vaccines Market by Country: Market Share (%), 2020
Figure 5.12 Asia Pacific Live Vaccines Market by Country: Market Share (%), 2025
Figure 5.13 Asia Pacific Live Vaccines Market by Country: Market Share (%), 2030
Figure 5.14 Latin America Live Vaccines Market by Country: Market Share (%), 2020
Figure 5.15 Latin America Live Vaccines Market by Country: Market Share (%), 2025
Figure 5.16 Latin America Live Vaccines Market by Country: Market Share (%), 2030
Figure 5.17 MEA Live Vaccines Market by Country: Market Share (%), 2020
Figure 5.18 MEA Live Vaccines Market by Country: Market Share (%), 2025
Figure 5.19 MEA Live Vaccines Market by Country: Market Share (%), 2030
Figure 6.1 SWOT Analysis of the Global Live Vaccines Market
Figure 6.2 PEST Analysis of the Global Live Vaccines Market
Figure 6.3 Market Trends Analysis of the Global Live Vaccines Market
AstraZeneca
Bavarian Nordic A/S
DAIICHI SANKYO COMPANY, LIMITED
Emergent BioSolutions Inc.
GlaxoSmithKline plc
Inovio Pharmaceuticals, Inc.
Merck & Co., Inc.
Mitsubishi Tanabe Pharma Corporation
Pfizer
Sanofi
Serum Institute of India
Vivaldi Biosciences Inc.
List of Organisations Mentioned in the Report
Advisory Committee on Immunization Practices (ACIP)
American Academy of Family Physicists (AAFP)
American Academy of Pediatrics (AAP)
American College of Obstetricians and Gynecologists (ACOG)
American College of Physicians (ACP),
American Immunization Registry Association
Biomedical Advanced Research and Development Authority
Centers for Disease Control and Prevention (CDC)
Centers for Medicare & Medicaid Services (CMS).
Centre for Biologics Evaluation and Research (CBER)
GAVI
IDSA
Immunization Action Coalition
Institutional Review Board (IRB
International Vaccine Institute
National Center for Immunization and Respiratory Diseases
National Institutes of Health (NIH)
National Vaccine Information Center
Pan American Health Organization (PAHO)
Pharmaceutical Research and Manufacturers Association of America (PhRMA)
Public Health Agency of Canada
Strategic Advisory Group of Experts (SAGE)
The Global Polio Eradication Initiative
The International Federation of Red Cross and Red Crescent Societies
The United Nations Children's Fund
U.S. Department of Health and Human Services (HHS)
U.S. Food & Drug Administration
UNICEF
Universal Immunisation Programme (India)
VAERS (Vaccine Adverse Event Reporting System)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Global Live Vaccines Market Forecast 2020-2030
Related reports
Inactivated Vaccines Market Report 2020-2030
Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine...
Full DetailsPublished: 13 May 2021Top 25 Vaccines Market Forecast to 2029
Visiongain expects market growth from $25.19bn in 2018 to $40.80bn in 2024, growing at a CAGR of 8.42%. The developing...
Full DetailsPublished: 27 February 2020Pharma Leader Series: Top 26 Asthma & COPD Companies 2020-2030
The global asthma & COPD therapies market was valued at $36.21bn in 2018 and is projected to grow to $60.8bn...
Full DetailsPublished: 17 February 2020Clinical Trial Supply and Logistics Market for Pharma 2019-2029
The global clinical trial supply and logistics market for pharma is estimated to have reach $17.1bn in 2018, dominated by...
Full DetailsPublished: 18 April 2019Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030
Visiongain assesses that the clinical research organizations (CROs) market will generate revenues of $38.0 billion in 2020.
...Full DetailsPublished: 12 February 2020Drug Discovery Outsourcing Market Report 2020-2030
The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug...
Full DetailsPublished: 24 August 2020Precision Medicine Market Report 2020-2030
Our 193 pages report provides 107 tables, 107 charts, and graphs. Read on to discover the most lucrative areas in...
Full DetailsPublished: 27 May 2020Global ePharmacy Market 2018-2028
The global ePharmacy market is expected to grow at a CAGR of 16.7% in the first half of the forecast...
Full DetailsPublished: 23 January 2018Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Report 2023-2033
The CBRN defence market is projected to grow at a CAGR of 6.0% by 2033....Full DetailsPublished: 05 December 2022Novel Coronavirus (COVID-19) Drugs in Development Market Forecast 2020-2030
Our 180+ page report provides 100+ tables, charts, and graphs. Read on to discover the most key areas in the...
Full DetailsPublished: 18 May 2020
Download sample pages
Complete the form below to download your free sample pages for Global Live Vaccines Market Forecast 2020-2030
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Latest Pharma news
Visiongain Publishes Biologics Market Report 2024-2034
The biologics market is estimated at US$447 billion in 2023 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.
20 November 2023
Visiongain Publishes mRNA Vaccines Market Report 2023-2033
The global mRNA Vaccines market is estimated at US$11,773.3 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.
08 November 2023
Visiongain Publishes Stem Cell Technologies and Applications Market Report 2023-2033
The global Stem Cell Technologies and Applications market is estimated at US$10,059.6 million in 2023 and is projected to grow at a CAGR of 8.7% during the forecast period 2023-2033.
06 November 2023
Visiongain Publishes Neurology Clinical Trials Market Report 2023-2033
The global Neurology Clinical Trials market is valued at US$9,609.2 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033.
01 November 2023